What the company does
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, a Phase 3-ready therapeutic candidate with the potential to establish a new standard of care (SOC) for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases and LYT-200, a fully human IgG4 monoclonal antibody. The company also develops SPT-300, a Glyphed oral prodrug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable …
What the weekly tape is saying
PRTC closed the latest completed week at 131.2 GBP. The 4-week return is -0.5% and the 12-week return is 13.5%. Trend Signal is active, Market Dynamics is 0.70. Setup signature: Balanced read with a 43/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 126.6 GBP
- Vs Trend Line
- 3.7%
- Fair Value
- 159.2 GBP
- Vs Fair Value
- -17.6%
- 52W High
- 148.0 GBP
- 52W Low
- 104.7 GBP
- Drawdown
- -11.4%
- Range Position
- 61.2%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 4 weeks
- 52W Active Weeks
- 4
- 52W Active Breadth
- 7.7%
- Sector Scope
- GB Healthcare
- Sector Rank
- 8 of 78
- Sector Percentile
- 90.9%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
GB Healthcare
- Tracked Peers
- 78
- 4W Rank
- 32 of 78
- Avg 1W
- -2.0%
- Avg 4W
- -0.2%
- Trend Breadth
- 38.5%
- Positive MD
- 55.1%
GB Biotechnology
- Tracked Peers
- 29
- 4W Rank
- 11 of 29
- Avg 1W
- -3.7%
- Avg 4W
- -0.5%
- Trend Breadth
- 37.9%
- Positive RS
- 34.5%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.70
- 4W MD Change
- 51.0%
- Relative Strength
- -4.35
- 4W RS Change
- -47.7%
- Expectation
- Negative
- Probability
- 43.14%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 2.2M
- 13W Average
- 3.1M
- 52W Average
- 2.8M
- Vs 13W
- 0.7x
- Vs 52W
- 0.8x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 6.9%
- 52W Volatility
- 5.1%
- Upside Weeks
- 26
- Downside Weeks
- 25
- Downside Breadth
- 48.1%
- Avg Gain / Loss
- 4.1% / -4.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- LSE
- Country
- GB
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- GBP
- Market Cap
- 337.9M
Opportunity signals
- Trend Signal is active with a 4-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Market Dynamics is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Price is below Fair Value, so the market is still discounting the latest tape.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 131.2 GBP | 4.0% | 126.6 GBP | 159.2 GBP | 0.70 | -4.35 | 2.2M | On |
| 5 Jun 2026 | 126.2 GBP | -9.1% | 126.3 GBP | 159.8 GBP | 0.76 | -7.54 | 2.3M | On |
| 29 May 2026 | 138.8 GBP | 0.9% | 126.2 GBP | 160.6 GBP | 0.75 | 0.77 | 1.7M | On |
| 22 May 2026 | 137.6 GBP | 4.4% | 126.0 GBP | 161.2 GBP | 0.81 | -0.96 | 2.8M | On |
| 15 May 2026 | 131.8 GBP | 3.6% | 125.9 GBP | 161.7 GBP | 0.46 | -2.94 | 2.7M | Off |
| 8 May 2026 | 127.2 GBP | -8.4% | 125.9 GBP | 162.2 GBP | 0.43 | -6.96 | 2.8M | Off |
| 1 May 2026 | 138.8 GBP | 13.2% | 126.0 GBP | 162.7 GBP | 0.34 | -0.08 | 4.7M | Off |
| 24 Apr 2026 | 122.6 GBP | -7.4% | 126.1 GBP | 163.2 GBP | -0.14 | -12.09 | 2.8M | Off |
| 17 Apr 2026 | 132.4 GBP | 9.1% | 126.2 GBP | 163.8 GBP | -0.39 | -8.04 | 4.3M | Off |
| 10 Apr 2026 | 121.4 GBP | 7.4% | 125.8 GBP | 164.3 GBP | -0.81 | -15.45 | 4.9M | Off |
| 3 Apr 2026 | 113.0 GBP | 2.7% | 125.5 GBP | 164.9 GBP | -0.97 | -20.44 | 5.5M | Off |
| 27 Mar 2026 | 110.0 GBP | -4.8% | 125.6 GBP | 165.6 GBP | -0.81 | -19.50 | 2.0M | Off |
| 20 Mar 2026 | 115.6 GBP | -4.6% | 126.1 GBP | 166.3 GBP | -0.51 | -15.68 | 2.0M | Off |
| 13 Mar 2026 | 121.2 GBP | -1.9% | 126.9 GBP | 167.0 GBP | -0.13 | -14.94 | 1.1M | Off |